Rusu, E;
Jinga, M;
Rusu, F;
Ciurtin, C;
Enache, G;
Dragomir, A;
Cristescu, V;
... Radulian, G; + view all
(2013)
Statin therapy in patients with diabetes and hepatitis C.
Farmacia
, 61
(6)
pp. 1204-1215.
Preview |
Text
Statin therapy in diabetes and hepatitis C.pdf - Published Version Download (269kB) | Preview |
Abstract
The objective of this study was to determine the effects of statin therapy (atorvastatin) on serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels in patients with type 2 diabetes mellitus (T2DM) and chronic hepatitis C (CHC). A number of 77 patients with T2DM and CHC were selected, treated with atorvastatin, 20 mg, for 6 months, who underwent anthropometric measurements and biochemical tests (including fasting serum glucose, lipid profile, liver profile, cytokines profile) at baseline, after 1 month (clinical and biochemical profile for safety) and after 6 months of treatment. The patients’ average age was 52.53±9.7 years. Plasma low-density lipoprotein cholesterol (LDL-C) (-32.4 mg/dL), triglycerides (-29.7 mg/dL), total cholesterol (-32.8 mg/dL) decreased (p<0.05), and high-density lipoprotein cholesterol (HDL-C) (+3.04 mg/dL) increased (p<0.05), after 6 months. Atorvastatin treatment was associated with decreases of AST, ALT, and also leptin and interleukin-6 (IL-6) levels (all p<0.05) but we did not find any effect on plasma tumor necrosis factor-alpha (TNF-α) (p=0.119). Atorvastatin was an effective and well tolerated treatment for lowering total cholesterol, LDL-C, triglycerides in patients with CHC. Among patients with CHC there was no significant elevation of liver enzymes during statin treatment, and we even noticed an improvement of hepatic profile.
| Type: | Article |
|---|---|
| Title: | Statin therapy in patients with diabetes and hepatitis C |
| Open access status: | An open access version is available from UCL Discovery |
| Publisher version: | https://farmaciajournal.com/issue-articles/statin-... |
| Language: | English |
| Additional information: | This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Pharmacology & Pharmacy, atorvastatin, diabetes, hepatitis C, SIMPLE NONINVASIVE INDEX, INSULIN-RESISTANCE, COMBINATION THERAPY, HIGH PREVALENCE, ATORVASTATIN, FIBROSIS, MELLITUS, ADIPONECTIN, GLUCOSE, MARKERS |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10131652 |
Archive Staff Only
 |
View Item |
